Manage Your Liver
Q:

Liver cancer may still develop after successful DAA therapy, especially in patients with cirrhosis

Liver cancer may still develop after successful DAA therapy, especially in patients with cirrhosis
A:

Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hepatitis C.

 

Cirrhosis – a risk factor for liver cancer

 

A recent study presented at The Liver Meeting held by the American Association for the Study of Liver Diseases found patients with hepatitis C who take DAA medication are at an increased risk for more aggressive, infiltrative patterns of cancer, should they develop it.

 

Dr. Alberti, professor of gastroenterology at University of Padova in Italy, and his team recently looked at the incidence of new cases of liver cancer among HCV patients with advanced liver disease (such as cirrhosis) who were treated with DAAs. In different analyses of the data, Dr. Alberti’s team found elevated liver enzymes and low platelet count to be associated with liver cancer risk. The best baseline predictor of liver cancer risk was APRI scores, which calculate scarring or fibrosis in the liver. The researchers find the risk of developing liver cancer increased linearly by 10 per cent at each one-point increase in APRI value. This meant that cirrhotic patients with more severe fibrosis are at higher risk of liver cancer.

 

Risk of liver cancer remains even after DAA

 

“The results of this study indicate that there is no pharmacological prevention of HCC even with successful antiviral therapy, at least during the first six to 12 months after initiation of treatment,” Dr. Alberti stated.

 

Another study conducted by Dr. Thomas Baumert at the University of Strasbourg, France investigated the mechanism behind the development of HCC following HCV cure. They found that HCV infections produce changes in the liver that were only partially reversed by DAAs and that they persist after HCV cure. Both studies suggest liver cancer may still develop even after successful DAA treatment, as DAAs only remove the hepatitis C virus, while protection from liver cancer is not guaranteed.

 

Post-treatment monitoring of cirrhosis and care

 

In view of the above, it is essential that patients treated with DAAs with advanced liver disease like cirrhosis should continue to be monitored for HCC. Dr. Alberti’s team also recommended that those with compensated cirrhosis who have undergone successful DAA treatment should be monitored for liver cancer after 50 years of age. 

 

Apart from monitoring, post-treatment care for the liver is also necessary. As mentioned previously, DAAs only remove the hepatitis virus, but not the damage that has been done. Therefore, to prevent advancement of liver disease and liver cancer, we must first enhance the liver’s recovery ability and reverse fibrosis so that normal liver function is resumed.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Cirrhosis has always been a tricky liver condition to tackle, given its complications and symptoms that are difficult to manage. A recent study published in the American Journal of Physiology-Gastrointestinal and Liver Physiology mentions that lowering the inflammation level of cirrhosis patients’ oral cavity helps improve the overall inflammation level in the body, which could help minimize some of the symptoms cirrhosis patients experience. This study highlights the i
A:
As many of you may have known, reports of the new hepatitis C treatment being associated with a higher risk of liver cancer were found when the treatment came out. One of the most notable cases is the development of a 7 cm cancer tumour in just 6 months after the patient receiving the new treatment. Researchers have been investigating on this issue, and a
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.